Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Cosmet Dermatol ; 21(11): 5680-5695, 2022 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-35933690

RESUMEN

BACKGROUND: Melasma is an acquired hyperpigmentation disorder. Microneedling is an alternative treatment for melasma especially by improving penetration of pharmacological agents into the skin. OBJECTIVE: The main objective of this review was to systematize and analyze available evidence on the efficacy and safety of microneedling alone or associated with topical agents in reducing skin stains and improving melasma-related quality of life in adult patients. METHODS: Only randomized clinical trials were included. The following databases were consulted: MEDLINE, Embase, Cochrane, and the gray literature. The Cochrane risk-of-bias tool for randomized trials (RoB 2.0) was used to assess risk of bias. RESULTS: The search retrieved 719 records and seven studies were included. A total of 368 participants (96.19% women) were evaluated. Two studies were split-face. Most of the studies evaluated microneedling associated with tranexamic acid. High risk of bias was presented by most studies, especially in the safety outcome. A significant decrease was observed in the MASI, mMASI, or hemi-MASI scores, regardless of the topical agents associated. Meta-analysis was not possible due to the heterogeneity of the studies. CONCLUSION: Based on the results of this review, microneedling can, in association with topical agents or isolated, be used safely in the treatment of melasma in the clinical practice, obtaining results on reduction of stain severity and improvement of patients' quality of life.


Asunto(s)
Hiperpigmentación , Melanosis , Ácido Tranexámico , Adulto , Humanos , Femenino , Masculino , Calidad de Vida , Administración Cutánea , Melanosis/tratamiento farmacológico , Hiperpigmentación/tratamiento farmacológico , Terapia Combinada , Resultado del Tratamiento
2.
Res Social Adm Pharm ; 17(1): 1997-2001, 2021 01.
Artículo en Inglés | MEDLINE | ID: mdl-33023831

RESUMEN

This article is a report from an experience about a work developed by Farmácia Universitária at UFRJ (FU-UFRJ) during the nCov-19 pandemic period. The aim of this work was to describe its contribution in the production of antiseptic supplies used to prevent contagion by the new coronavirus. The work routine at the pharmacy has been changed to allow the implementation of local workflow during the pandemic, and to adapt the protection rules to meet the safety measures. FU-UFRJ started to manipulate two antiseptic formulations: 70% ethyl alcohol and gel alcohol, which are included in the National Form, manufacturing around 100 L of these formulations, weekly, to donate to different health units. The experience enabled the adaptation to emergency health standards, planning and meaningful guidance to pharmacists and technicians to attend clinics at university hospitals, vaccination center and UFRJ city hall, in order to facilitate the access to adequate hand hygiene to the population.


Asunto(s)
COVID-19/prevención & control , Desinfectantes para las Manos/química , Farmacéuticos/organización & administración , Servicio de Farmacia en Hospital/organización & administración , Antiinfecciosos Locales/química , Antiinfecciosos Locales/provisión & distribución , Composición de Medicamentos/métodos , Etanol/química , Geles , Desinfección de las Manos/métodos , Higiene de las Manos/métodos , Desinfectantes para las Manos/provisión & distribución , Humanos , Flujo de Trabajo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA